Correlation Between Black Diamond and Bluebird Bio

Can any of the company-specific risk be diversified away by investing in both Black Diamond and Bluebird Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Bluebird Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Black Diamond Therapeutics and Bluebird bio, you can compare the effects of market volatilities on Black Diamond and Bluebird Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Bluebird Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Bluebird Bio.

Diversification Opportunities for Black Diamond and Bluebird Bio

0.65

Correlation Coefficient

Black Diamond  Bluebird Bio

Poor diversification

The 3 months correlation between Black and Bluebird is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Bluebird bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluebird bio and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Bluebird Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluebird bio has no effect on the direction of Black Diamond i.e., Black Diamond and Bluebird Bio go up and down completely randomly.

Pair Corralation between Black Diamond and Bluebird Bio

Given the investment horizon of 90 days Black Diamond Therapeutics is expected to generate 0.76 times more return on investment than Bluebird Bio. However, Black Diamond Therapeutics is 1.31 times less risky than Bluebird Bio. It trades about -0.04 of its potential returns per unit of risk. Bluebird bio is currently generating about -0.11 per unit of risk. If you would invest  219.00  in Black Diamond Therapeutics on December 22, 2024 and sell it today you would lose (41.00) from holding Black Diamond Therapeutics or give up 18.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Black Diamond Therapeutics  vs.  Bluebird bio

Black Diamond Therap

Risk-Adjusted Performance

Very Weak

Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Bluebird bio

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bluebird bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Black Diamond and Bluebird Bio

The main advantage of trading using opposite Black Diamond and Bluebird Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Bluebird Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluebird Bio will offset losses from the drop in Bluebird Bio's long position.

The idea behind Black Diamond Therapeutics and Bluebird bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.